Learn more...

aischannel coffee-with

Only logged in users can watch the video

CME with D3 dissection for colon cancer

Can you imagine sharing a coffee with an internationally renowned surgeon and having a direct, pleasant and informal conversation?
Thanks to the new "A COFFEE WITH" feature of AIS you will be able to do so!!!
You will have a coffee agenda so you can choose the day and time and enjoy a dose of surgical caffeine of the highest level.
Shall we reserve your stool?

This session will cover a Complete Mesocolic Excision (CME) with D3 dissection for colon cancer. This is a modern type of combined surgical procedure. Currently, both European and Japanese doctors are doing an increasing number of these procedures with lymph node dissection and Complete Mesocolic Excision.

First, he goes over statistics regarding how many cases are performed each year in Japan, then moves on to provide a brief overview of the history of D3 dissection surgery in Japan.   

Dr. Tsuyoshi Konisihi affirms that many studies with oncologic outcomes for colon cancer have not improved as much as the outcomes for rectal cancer.

When it comes to the learning curve of CME procedures in rectal cancer, we should point out that many surgeons are performing this type of surgery as ‘minimally invasive surgery’ and there’s good transmission of knowledge on this topic. Nevertheless, while there’s no exact information about the learning curve, it is the doctor’s opinion that a laparoscopic procedure needs at least 10 cases to feel comfortable. 

Bearing in mind that we are coping with a treatable metastasis, it is necessary to perform CME with D3 dissection in metastatic cancer. Also, the doctor tells us that this kind of surgery was treated as being very specific in the past but over the years these operations have become more common.

In conclusion, the prevention of colorectal cancers is very important for the maintenance of a healthy population. 

Dr. Tsuyoshi Konishi is an associate professor of Colon and Rectal Surgery at the University of Texas M.D. Anderson Cancer Center, in Houston, USA. 

After completion of advanced training in the field of Surgical Oncology and Colorectal Minimally Invasive Surgery at top institutions including the University of Tokyo, Cancer Institute Hospital of the JFCR and Memorial Sloan-Kettering Cancer Center, Dr. Konishi served as an attending colorectal surgeons since 2010, and Head Attending since 2017, at Cancer Institute Hospital of the Japanese Foundation for Cancer Research in Tokyo, Japan. He took a leadership in advancing a minimally invasive surgery program for complex colorectal cancer.

Dr. Konishi’s research interest includes combining multidisciplinary approaches for complex colorectal cancer, including neoadjuvant therapy, extended surgical resection and a minimally invasive surgery. Particularly, he has been taking an international leadership in studying lateral pelvic lymph node dissection for rectal cancer.

He has given more than 80 invited lectures at international academic meetings. He has published more than 150 articles in the top-rated journals with more than 5,000 citations. He has been awarded from multiple major international and domestic academic societies for his works on novel minimally invasive approaches for complex colorectal cancer surgeries. 

He is a member of the Editorial Board of multiple international journals such as Annals of Surgical Oncology and Techniques in Coloproctology, and serves as an assistant editor of International Journal of Surgery. 

Dr. Konishi is the Director of the Japan Society of Laparoscopic Colorectal Surgery and the Councilor of the Japan Society for Endoscopic Surgery.